Arcturus Therapeutics Holdings Inc

NASDAQ:ARCT  
20.77
+4.16 (+25.04%)
Other Pre-Announcement

Arcturus Posts Quarterly Loss Per Share $1.94

Published: 05/09/2022 21:01 GMT
Arcturus Therapeutics Holdings Inc (ARCT) - Arcturus Therapeutics Holdings - Arct-154 Booster Data Show 54- and 46-fold Increases in Neutralizing Antibody Response Against Omicron Ba.
1 and Ba.
2.
Arcturus Therapeutics Holdings Inc - Cash and Cash Equivalents Were $319.7 Million As of March 31, 2022.
Arcturus Therapeutics Holdings Inc - Based on Current Pipeline, Co's Cash Position is Expected to Be Sufficient to Support Operations Into Late 2023.
Arcturus Therapeutics Holdings Inc - Qtrly Loss per Share $1.94.